DORADO, PR / ACCESS Newswire / June 16, 2025 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB
BSV), a compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, chemical, medical device, cosmetic, food and allied products industries, today announced that revenues for the three and six months ended April 30, 2025 were approximately $2.4 million and $4.9, million, respectively. Revenues for the three and six months ended April 30, 2024 were approximately $2.3 million and $4.8 million, respectively.
